Jacobs SlifkaKMNewtonAEMahonBE.Vibrio alginolyticus infections in the USA, 1988-2012. Epidemiol Infect. 2017;145(7):1491-1499. doi:10.1017/S0950268817000140.
2.
NorfolkWAShueCHendersonWMGlinskiDALippEK.Vibrio alginolyticus growth kinetics and the metabolic effects of iron. Microbiol Spectr. 2023;11(6):e0268023. doi:10.1128/spectrum.02680-23.
AltekruseSFBishopRDBaldyLM, et al. Vibrio gastroenteritis in the US Gulf of Mexico region: the role of raw oysters. Epidemiol Infect. 2000;124(3):489-495. doi:10.1017/s0950268899003714.
5.
DechetAMYuPAKoramNPainterJ.Nonfoodborne Vibrio infections: an important cause of morbidity and mortality in the United States, 1997-2006. Clin Infect Dis. 2008;46(7):970-976. doi:10.1086/529148.
OliverJD.Wound infections caused by Vibrio vulnificus and other marine bacteria. Epidemiol Infect. 2005;133(3):383-391. doi:10.1017/s0950268805003894.
8.
Paula Fernández-SarrateaMBeteta-LópezAEzcurra-HernándezPVinuesa-VelascoV. Chronic simple otitis media due to Vibrio alginolyticus. Enferm Infecc Microbiol Clin. 2022;40(10):582-583. doi:10.1016/j.eimce.2022.06.010.
9.
FeingoldMHKumarML.Otitis media associated with Vibrio alginolyticus in a child with pressure-equalizing tubes. Pediatr Infect Dis J. 2004;23(5):475-476. doi:10.1097/01.inf.0000126592.19378.30.
10.
LiuJWLeeIKTangHJ, et al. Prognostic factors and antibiotics in Vibrio vulnificus septicemia. Arch Intern Med. 2006;166(19):2117-2123. doi:10.1001/archinte.166.19.2117.
11.
KimSEShinSUOhTH, et al. Outcomes of third-generation cephalosporin plus ciprofloxacin or doxycycline therapy in patients with Vibrio vulnificus septicemia: a propensity score-matched analysis. PLoS Negl Trop Dis. 2019;13(6):e0007478. doi:10.1371/journal.pntd.0007478.
12.
ChenSCLeeYTTsaiSJ, et al. Antibiotic therapy for necrotizing fasciitis caused by Vibrio vulnificus: retrospective analysis of an 8 year period. J Antimicrob Chemother. 2012;67(2):488-493. doi:10.1093/jac/dkr476.
13.
Committee on Infectious Diseases; American Academy of Pediatrics. Other vibrio infections. In: KimberlinDWBanerjeeRBarnettEDLynfieldRuthSawyerMH, eds. Red Book: 2024-2027 Report of the Committee on Infectious Diseases. 33rd ed.Itasca, IL: American Academy of Pediatrics; 2024:955-957.
14.
CostaWFGiambiagi-deMarvalMLaportMS.Antibiotic and heavy metal susceptibility of non-cholera vibrio isolated from marine sponges and sea urchins: could they pose a potential risk to public health?Antibiotics. 2021;10(12):1561. doi:10.3390/antibiotics10121561.